Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AFL NYSE:CNC NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFLAflac$125.61+1.0%$118.64$96.95▼$125.93$63.93B0.611.90 million shs1.52 million shsCNCCentene$63.35-0.6%$63.46$25.08▼$69.36$31.31B1.074.10 million shs2.81 million shsHUMHumana$388.56-1.5%$364.10$163.11▼$428.88$46.74B0.711.28 million shs740,260 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFLAflac0.00%+0.65%+6.42%+9.50%+22.13%CNCCentene0.00%-4.43%-2.13%+51.39%+115.50%HUMHumana0.00%-2.98%+3.49%+80.51%+64.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFLAflac$125.61+1.0%$118.64$96.95▼$125.93$63.93B0.611.90 million shs1.52 million shsCNCCentene$63.35-0.6%$63.46$25.08▼$69.36$31.31B1.074.10 million shs2.81 million shsHUMHumana$388.56-1.5%$364.10$163.11▼$428.88$46.74B0.711.28 million shs740,260 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFLAflac0.00%+0.65%+6.42%+9.50%+22.13%CNCCentene0.00%-4.43%-2.13%+51.39%+115.50%HUMHumana0.00%-2.98%+3.49%+80.51%+64.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFLAflac 2.31Hold$116.17-7.52% DownsideCNCCentene 2.25Hold$64.611.99% UpsideHUMHumana 2.39Hold$327.17-15.80% DownsideCurrent Analyst Ratings BreakdownLatest AFL, HUM, and CNC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/23/2026AFLAflac Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B+) ➝ Buy (A-)7/22/2026AFLAflac TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$101.00 ➝ $110.007/21/2026AFLAflac JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$108.00 ➝ $117.007/20/2026HUMHumana Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$410.007/17/2026CNCCentene Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)7/14/2026HUMHumana TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$211.00 ➝ $350.007/14/2026CNCCentene TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$47.00 ➝ $65.007/14/2026CNCCentene Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$71.00 ➝ $78.007/14/2026HUMHumana Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$320.00 ➝ $415.007/13/2026CNCCentene Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetEqual Weight$56.00 ➝ $69.007/13/2026HUMHumana Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$227.00 ➝ $502.00(Data available from 7/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFLAflac$17.16B3.72$9.32 per share13.48$56.27 per share2.23CNCCentene$194.78B0.16$4.68 per share13.53$40.76 per share1.55HUMHumana$129.66B0.36$24.02 per share16.18$147.47 per share2.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFLAflac$3.65B$8.8114.2616.401.9425.60%13.88%3.34%8/6/2026 (Estimated)CNCCentene-$6.67B-$13.14N/A14.300.50-3.25%5.57%1.54%7/28/2026 (Estimated)HUMHumana$1.19B$9.3541.5625.042.120.82%10.45%3.75%7/29/2026 (Estimated)Latest AFL, HUM, and CNC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026AFLAflac$1.76N/AN/AN/A$4.11 billionN/A7/29/2026Q2 2026HUMHumana$7.26N/AN/AN/A$40.57 billionN/A7/28/2026Q2 2026CNCCentene$1.08N/AN/AN/A$47.64 billionN/A4/29/2026Q1 2026AFLAflac$1.80$1.75-$0.05$1.98$4.20 billion$4.24 billion4/29/2026Q1 2026HUMHumana$9.97$10.31+$0.34$9.83$39.37 billion$39.65 billion4/28/2026Q1 2026CNCCentene$2.23$3.37+$1.14$3.11$47.53 billion$49.94 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAFLAflac$2.441.94%+15.68%27.70%44 YearsCNCCenteneN/AN/AN/AN/AN/AHUMHumana$3.540.91%+7.20%37.86%N/ALatest AFL, HUM, and CNC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/27/2026AFLAflacquarterly$0.612.08%5/20/20265/20/20266/1/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFLAflac0.260.110.11CNCCentene0.761.121.12HUMHumana0.661.771.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFLAflac67.44%CNCCentene93.63%HUMHumana92.38%Insider OwnershipCompanyInsider OwnershipAFLAflac0.80%CNCCentene0.37%HUMHumana0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFLAflac12,716508.98 million504.91 millionOptionableCNCCentene61,100493.80 million491.97 millionOptionableHUMHumana67,060120.06 million119.82 millionOptionableAFL, HUM, and CNC HeadlinesRecent News About These CompaniesWeiss Asset Management LP Buys 12,685 Shares of Humana Inc. $HUM3 hours ago | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Raises Stock Position in Humana Inc. $HUM4 hours ago | marketbeat.comSustainable Insight Capital Management LLC Boosts Stock Position in Humana Inc. $HUMJuly 25 at 6:15 AM | marketbeat.comDimensional Fund Advisors LP Sells 15,985 Shares of Humana Inc. $HUMJuly 25 at 3:37 AM | marketbeat.comAllspring Global Investments Holdings LLC Cuts Stock Position in Humana Inc. $HUMJuly 25 at 3:05 AM | marketbeat.comCan Humana Beat Q2 Earnings Estimates on Growing Premiums?July 24 at 1:41 PM | zacks.comKBC Group NV Trims Holdings in Humana Inc. $HUMJuly 24 at 5:05 AM | marketbeat.comKopernik Global Investors LLC Takes Position in Humana Inc. $HUMJuly 23 at 5:36 AM | marketbeat.comSEB Asset Management AB Purchases Shares of 24,228 Humana Inc. $HUMJuly 23 at 4:56 AM | marketbeat.comCommerzbank Aktiengesellschaft FI Acquires Shares of 2,625 Humana Inc. $HUMJuly 23 at 3:44 AM | marketbeat.comHumana (HUM) Expected to Beat Earnings Estimates: Should You Buy?July 22, 2026 | zacks.comHumana (HUM) Projected to Announce Earnings on WednesdayJuly 22, 2026 | marketbeat.comMeeder Asset Management Inc. Sells 5,762 Shares of Humana Inc. $HUMJuly 22, 2026 | marketbeat.comSwiss National Bank Boosts Holdings in Humana Inc. $HUMJuly 22, 2026 | marketbeat.comHumana Inc. $HUM Shares Sold by California Public Employees Retirement SystemJuly 22, 2026 | marketbeat.comHumana (HUM) is a Great Momentum Stock: Should You Buy?July 21, 2026 | zacks.comHumana Inc. $HUM Shares Sold by Bank of New York Mellon CorpJuly 21, 2026 | marketbeat.comHeartland Advisors Inc. Sells 2,535 Shares of Humana Inc. $HUMJuly 20, 2026 | marketbeat.comFifth Third Bancorp Has $3.98 Million Stock Position in Humana Inc. $HUMJuly 19, 2026 | marketbeat.comWatershed Asset Management L.L.C. Takes $474,000 Position in Humana Inc. $HUMJuly 18, 2026 | marketbeat.comZacks Research Weighs in on Humana's Q4 Earnings (NYSE:HUM)July 18, 2026 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AIBy Jeffrey Neal Johnson | July 2, 20263 Overlooked Stocks Positioned for the Next Market RotationBy Bridget Bennett | July 13, 20263 Picks-and-Shovels Stocks Powering the Humanoid Robotics BuildoutBy Ryan Hasson | July 17, 2026A Boring Dividend Growth Strategy Becomes a Solid Defensive PlayBy Nathan Reiff | July 22, 2026AFL, HUM, and CNC Company DescriptionsAflac NYSE:AFL$125.61 +1.27 (+1.02%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$125.53 -0.08 (-0.06%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.Centene NYSE:CNC$63.35 -0.39 (-0.61%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$63.25 -0.10 (-0.16%) As of 07/24/2026 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Humana NYSE:HUM$388.56 -5.94 (-1.50%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$389.32 +0.76 (+0.20%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
